Literature DB >> 18718455

Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death.

Tori A Matthews-Roberson1, Rodrigo A Quintanilla, Huiping Ding, Gail V W Johnson.   

Abstract

It has been previously reported that an Asp421 cleaved form of tau is toxic when expressed in cells. The purpose of this study was to understand if, and in what manner, the presence of Asp421 cleaved tau in neurons, which is generated by caspase cleavage, might facilitate neuronal death in Alzheimer's disease (AD). For these studies we used immortalized cortical neurons that inducibly express either a full-length tau isoform (T4) or an isoform that has been pseudo-truncated at Asp421 (T4C3), to mimic caspase-3 cleavage. Neurons expressing either T4 or T4C3 were treated with thapsigargin, a drug, which has been shown to induce endoplasmic reticulum (ER) stress. Following long-term treatment with thapsigargin, cells expressing T4C3 presented with a marked increase in cell toxicity, underscored by differential activation of caspase-3 in comparison with cells expressing T4. Furthermore, we found that an inhibitor of the ERK1/2 signaling pathway, which is upregulated to different extents in each cell type, significantly reduced toxicity in both T4 and T4C3 cells. Our results suggest that the presence of Asp421 cleaved tau may sensitize neurons to ER stressors and possibly potentiate cell death processes during AD progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718455      PMCID: PMC2572685          DOI: 10.1016/j.brainres.2008.07.111

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

1.  The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis.

Authors:  L Fasulo; G Ugolini; M Visintin; A Bradbury; C Brancolini; V Verzillo; M Novak; A Cattaneo
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

2.  Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model.

Authors:  Pavan K Krishnamurthy; Gail V W Johnson
Journal:  J Biol Chem       Date:  2003-12-02       Impact factor: 5.157

3.  Proapoptotic effects of tau cleavage product generated by caspase-3.

Authors:  C W Chung; Y H Song; I K Kim; W J Yoon; B R Ryu; D G Jo; H N Woo; Y K Kwon; H H Kim; B J Gwag; I H Mook-Jung; Y K Jung
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

4.  Transient oxidative stress in SH-SY5Y human neuroblastoma cells results in caspase dependent and independent cell death and tau proteolysis.

Authors:  P K Krishnamurthy; J L Mays; G N Bijur; G V Johnson
Journal:  J Neurosci Res       Date:  2000-09-01       Impact factor: 4.164

5.  Memory and mental status correlates of modified Braak staging.

Authors:  E Grober; D Dickson; M J Sliwinski; H Buschke; M Katz; H Crystal; R B Lipton
Journal:  Neurobiol Aging       Date:  1999 Nov-Dec       Impact factor: 4.673

6.  Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3.

Authors:  Anna J Kim; Yuanyuan Shi; Richard C Austin; Geoff H Werstuck
Journal:  J Cell Sci       Date:  2004-12-07       Impact factor: 5.285

7.  Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.

Authors:  T Chris Gamblin; Feng Chen; Angara Zambrano; Aida Abraha; Sarita Lagalwar; Angela L Guillozet; Meiling Lu; Yifan Fu; Francisco Garcia-Sierra; Nichole LaPointe; Richard Miller; Robert W Berry; Lester I Binder; Vincent L Cryns
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-29       Impact factor: 11.205

Review 8.  Endoplasmic reticulum Ca(2+) homeostasis and neuronal death.

Authors:  A Verkhratsky; E C Toescu
Journal:  J Cell Mol Med       Date:  2003 Oct-Dec       Impact factor: 5.310

9.  Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.

Authors:  Qingmin Ruan; Mathieu Lesort; Marcy E MacDonald; Gail V W Johnson
Journal:  Hum Mol Genet       Date:  2004-02-12       Impact factor: 6.150

10.  Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.

Authors:  Shirley B Shelton; Pavan Krishnamurthy; Gail V W Johnson
Journal:  J Neurosci Res       Date:  2004-04-01       Impact factor: 4.164

View more
  20 in total

1.  Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.

Authors:  María José Pérez; Katiana Vergara-Pulgar; Claudia Jara; Fabian Cabezas-Opazo; Rodrigo A Quintanilla
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Truncated tau and Aβ cooperatively impair mitochondria in primary neurons.

Authors:  Rodrigo A Quintanilla; Philip J Dolan; Youngnam N Jin; Gail V W Johnson
Journal:  Neurobiol Aging       Date:  2011-03-29       Impact factor: 4.673

3.  A caspase cleaved form of tau is preferentially degraded through the autophagy pathway.

Authors:  Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

Review 4.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

5.  Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease.

Authors:  Rodrigo A Quintanilla; Tori A Matthews-Roberson; Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

6.  Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging.

Authors:  John C Means; Bryan C Gerdes; Simon Kaja; Nathalie Sumien; Andrew J Payne; Danny A Stark; Priscilla K Borden; Jeffrey L Price; Peter Koulen
Journal:  Neurochem Res       Date:  2016-05-25       Impact factor: 3.996

Review 7.  Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?

Authors:  Bo Su; Xinglong Wang; David Bonda; Gorge Perry; Mark Smith; Xiongwei Zhu
Journal:  Mol Neurobiol       Date:  2010-01-27       Impact factor: 5.590

8.  Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo.

Authors:  Vikram Khurana; Ilan Elson-Schwab; Tudor A Fulga; Katherine A Sharp; Carin A Loewen; Erin Mulkearns; Jaana Tyynelä; Clemens R Scherzer; Mel B Feany
Journal:  PLoS Genet       Date:  2010-07-15       Impact factor: 5.917

9.  Structure and pathology of tau protein in Alzheimer disease.

Authors:  Michala Kolarova; Francisco García-Sierra; Ales Bartos; Jan Ricny; Daniela Ripova
Journal:  Int J Alzheimers Dis       Date:  2012-05-29

10.  The role of tau in neurodegeneration.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2009-03-11       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.